Seaport Res Ptn Predicts TerrAscend Q1 Earnings

TerrAscend Corp. (OTCMKTS:TSNDF) – Investment analysts at Seaport Res Ptn issued their Q1 2026 EPS estimates for TerrAscend in a research note issued to investors on Sunday, March 9th. Seaport Res Ptn analyst S. Randhawa anticipates that the company will earn ($0.03) per share for the quarter. The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share. Seaport Res Ptn also issued estimates for TerrAscend’s Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at ($0.03) EPS and Q4 2026 earnings at ($0.03) EPS.

TerrAscend (OTCMKTS:TSNDF) last announced its earnings results on Thursday, March 6th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.04. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. The business had revenue of $74.35 million during the quarter, compared to the consensus estimate of $72.37 million.

Separately, Atb Cap Markets lowered TerrAscend from a “strong-buy” rating to a “hold” rating in a report on Monday, December 9th.

TerrAscend Stock Performance

OTCMKTS TSNDF opened at $0.44 on Tuesday. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.35 and a quick ratio of 0.69. The stock’s 50 day simple moving average is $0.56 and its 200-day simple moving average is $0.85. The company has a market cap of $129.00 million, a PE ratio of -1.57 and a beta of 1.64. TerrAscend has a 1-year low of $0.38 and a 1-year high of $2.20.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.